Post-approval studies (Phase 4)Study completedNCT03261635What this trial is testingRanibizumab Plus IndomethacinWho this might be right forMacular Edema Università degli Studi di Brescia 58
Not applicableStudy completedNCT01682382What this trial is testingAssociation of Macular Pigment Optical Density (MPOD) and Genetic Variants in Complement Factor H in Subjects With Choroidal Neovascular (CNV)Who this might be right forAge-related Macular DegenerationChoroidal Neovascular Age-related Macular Degeneration Sequenom, Inc. 45
Early research (Phase 1)Study completedNCT03814291What this trial is testingA Dose Escalation Study of IBI302 in Patients With Wet Age-related Macular DegenerationWho this might be right forNeovascular Age-related Macular Degeneration Innovent Biologics (Suzhou) Co. Ltd. 31
Large-scale testing (Phase 3)Study completedNCT07389577What this trial is testingCompare JL14002 to Lucentis® in Subjects With Wet Age-related Macular Degeneration (wAMD)Who this might be right forWet Age-related Macular Degeneration Jecho Biopharmaceuticals Co., Ltd. 443
Testing effectiveness (Phase 2)Study completedNCT00056823What this trial is testingIntravitreal Injections of rhuFab V2 in Combination With Visudyne in Subjects With Age Related Macular Degeneration (AMD)Who this might be right forAge-Related Maculopathy Genentech, Inc. 168
Large-scale testing (Phase 3)Study completedNCT03930641What this trial is testingStudy of the Safety of Brolucizumab 6 mg in Prefilled Syringe in Patients With Neovascular Age Related Macular DegenerationWho this might be right forNeovascular Age Related Macular Degeneration Novartis Pharmaceuticals 34
Post-approval studies (Phase 4)Study completedNCT01810042What this trial is testingIndocyanine Angiographic Changes of Choroidal Neovascularization by RanibizumabWho this might be right forExudative Age-related Macular Degeneration Pusan National University Hospital 49
Early research (Phase 1)Active Not RecruitingNCT01736059What this trial is testingClinical Trial of Autologous Intravitreal Bone-marrow CD34+ Stem Cells for RetinopathyWho this might be right forNon-exudative Age-related Macular DegenerationDiabetic RetinopathyRetina Vein Occlusion+2 more University of California, Davis 15
Not applicableUnknownNCT00893724What this trial is testingSupplemental Adjuvants for Intracellular Nutrition and TreatmentWho this might be right forNeovascular Age-related Macular DegenerationDiabetic Macular Edema Mid-Atlantic Retina Consultations, Inc. 60
Post-approval studies (Phase 4)Study completedNCT02142296What this trial is testingEylea to Treat Retinal Pigment Epithelial Detachment (RPED) Secondary to Wet Age-Related Macular Degeneration (wAMD)Who this might be right forRetinal Pigment Epithelial Detachment Secondary to Age-related Macular Degeneration London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 37
Not applicableStudy completedNCT07074054What this trial is testingAflibercept 8 mg for nAMD: Early Anatomical and Functional ChangesWho this might be right forPresence of Retinal FluidChanges in Macular Pigment Optical Density Federico II University 40
Not applicableStudy completedNCT02367365What this trial is testingNeovascular Morphology and Persistent Disease Activity Among Patients With NV AMDWho this might be right forNeovascular Age-Related Macular Degeneration Duke University 75
Post-approval studies (Phase 4)Ended earlyNCT00327470What this trial is testingAn Open Label Trial to Investigate Macugen for the Preservation of Visual Function in Subjects With Neovascular AMDWho this might be right forAge Related Macular Degeneration (AMD)Macular DegenerationChoroidal Neovascularization (CNV) Pfizer 288
Testing effectiveness (Phase 2)Study completedNCT02140151What this trial is testingProphylactic Ranibizumab for Exudative Age-related Macular DegenerationWho this might be right forAge-related Macular Degeneration Southern California Desert Retina Consultants, MC 108
Large-scale testing (Phase 3)Study completedNCT05989126What this trial is testingStudy to Evaluate an 8 mg Aflibercept (EYLEA®) Prefilled Syringe (PFS)Who this might be right forDiabetic Macular Edema (DME)Neovascular Age-Related Macular Degeneration (nAMD) Regeneron Pharmaceuticals 35
Large-scale testing (Phase 3)Ended earlyNCT00499590What this trial is testingSafety & Efficacy Study Evaluating the Combination of Bevasiranib & Lucentis Therapy in Wet AMDWho this might be right forMacular Degeneration OPKO Health, Inc. 338
Not applicableStudy completedNCT01527435What this trial is testingAddition of 20mg/Day Zeaxanthin to Triple Therapy Treatment Options for Age Related Macular Degeneration (ARMD)Who this might be right forExudative Age-Related Macular Degeneration The Retina Center of St. Louis County, PC 200
Large-scale testing (Phase 3)Study completedNCT01780935What this trial is testingEfficacy and Safety of Two Treatment Regimens of 0.5 mg Ranibizumab Intravitreal Injections Guided by Functional and/or Anatomical Criteria, in Patients With Neovascular Age-related Macular DegenerationWho this might be right forNeovascular Age-related Macular Degeneration Novartis Pharmaceuticals 671
Testing effectiveness (Phase 2)Active Not RecruitingNCT06087458What this trial is testingStudy of VOY-101 in Patients With Advanced Non-Neovascular Age-Related Macular DegenerationWho this might be right forAge-Related Macular DegenerationGeographic AtrophyNon-neovascular AMD+1 more Perceive Biotherapeutics, Inc. 60
Post-approval studies (Phase 4)Study completedNCT01958918What this trial is testingEfficacy of Ranibizumab Prn Treatment Compared to Aflibercept Bimonthly Intravitreal Injections on Retinal Thickness Stability in Patients With Wet AMDWho this might be right forNeovascular Age-related Macular Degeneration Novartis Pharmaceuticals 712